↓ Skip to main content

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Overview of attention for article published in Arthritis Research & Therapy, September 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy
1 policy source
patent
2 patents

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
Published in
Arthritis Research & Therapy, September 2013
DOI 10.1186/ar4318
Pubmed ID
Authors

Herbert SB Baraf, Michael A Becker, Sergio R Gutierrez-Urena, Edward L Treadwell, Janitzia Vazquez-Mellado, Claudia D Rehrig, Faith D Ottery, John S Sundy, Robert A Yood

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Australia 1 2%
Unknown 63 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 17%
Researcher 8 12%
Other 8 12%
Student > Master 7 11%
Student > Ph. D. Student 4 6%
Other 10 15%
Unknown 17 26%
Readers by discipline Count As %
Medicine and Dentistry 26 40%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 3 5%
Other 6 9%
Unknown 18 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2023.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Arthritis Research & Therapy
#1,264
of 3,381 outputs
Outputs of similar age
#46,173
of 215,408 outputs
Outputs of similar age from Arthritis Research & Therapy
#15
of 67 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.